logo
Lunit partners with Microsoft to develop AI cancer diagnostic tools

Lunit partners with Microsoft to develop AI cancer diagnostic tools

Yahoo5 hours ago
South Korean AI company Lunit is collaborating with Microsoft to help bring its AI-powered diagnostics for cancer detection into clinical practice.
According to Lunit, the partnership aligns with its vision to create AI tools that fit smoothly into everyday clinical care.
The collaboration will involve Lunit and Microsoft's development of a tool for customising AI models that will be embedded into Microsoft's Azure cloud platform, thereby allowing Lunit users to customise their AI models using site-specific clinical data.
Lunit adds that the approach will mitigate cross-site model performance variability, which it views as a key hurdle in the deployment of AI diagnostics in real-world clinical settings.
The developer also plans to use Microsoft's agentic AI frameworks, which are designed to support intelligent task automation, to develop workflow automation tools. According to Lunit, these solutions will simplify clinical decision-making and improve operational efficiency for its AI cancer diagnostic tools.
Lunit's AI tools include the SCOPE HER2 algorithm for human epidermal growth factor receptor 2 (HER2) biomarker evaluation in metastatic colorectal cancer (mCRC) patients undergoing HER2-targeted therapy, and INSIGHT DBT for identifying breast cancer in mammogram images.
Lunit CEO Brandon Suh commented: 'Our collaboration with Microsoft enables us to bring our AI to more providers through trusted platforms like Microsoft Azure, helping us expand access in the US and beyond.'
According to GlobalData analysis, the use of AI across healthcare is rapidly advancing, with the market projected to reach a valuation of around $19bn by 2027. Radiology has emerged as one of the most common areas in which AI is being applied – chiefly as a means to drive efficiencies and glean insights that humans evaluating radiologic images could miss.
Naveen Valluri, general manager of health and life sciences data and AI at Microsoft, commented: 'With Microsoft Azure, we are shaping an ecosystem that supports partners like Lunit in delivering scalable AI innovations.
'By combining our infrastructure with clinical-grade AI developed in close collaboration with leaders like Lunit, we're accelerating the development of integrated solutions for radiology and beyond.'
"Lunit partners with Microsoft to develop AI cancer diagnostic tools" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China's Rare Earth Origin Story, Explained
China's Rare Earth Origin Story, Explained

New York Times

time2 hours ago

  • New York Times

China's Rare Earth Origin Story, Explained

Rare earth metals were an afterthought for most world leaders until China temporarily suspended most exports of them a couple of months ago. But for almost half a century, they have received attention from the very top of the Chinese government. During his 27-year rule in China, Mao Zedong focused often on increasing how much iron and steel China produced, but seldom on its quality. The result was high production of weak iron and steel that could not meet the needs of the industry. In the late 1940s, metallurgists in Britain and the United States had developed a fairly low-tech way to improve the quality of ductile iron, which is widely used for pipelines, car parts and other applications. The secret? Add a dash of the rare earth cerium to the metal while it is still molten. It was one of the early industrial uses of rare earths. And unlike most kinds of rare earths, cerium was fairly easy to chemically separate from ore. When Deng Xiaoping emerged as China's paramount leader in 1978, he moved quickly to fix the country's iron and steel industry. Mr. Deng named a top technocrat, Fang Yi, as a vice premier and also as the director of the powerful State Science and Technology Commission. Want all of The Times? Subscribe.

Buy 2 AI-Powered Technology Services Stocks to Tap Lucrative Upside
Buy 2 AI-Powered Technology Services Stocks to Tap Lucrative Upside

Yahoo

time2 hours ago

  • Yahoo

Buy 2 AI-Powered Technology Services Stocks to Tap Lucrative Upside

The technology services industry is mature, with demand for services in good shape. Revenues, income and cash flows are anticipated to gradually returned to the pre-pandemic levels, enabling most industry players to pay out stable dividends. As a result, the industry flourished in 2024. The momentum gathered more pace in the first half of 2025. The Zacks-defined Technology Services industry currently ranks within the top 16% of Zacks Ranked Industries. Consequently, we expect it to outperform the market over the next three to six months. We recommend two artificial intelligence (AI)-powered technology services bigwigs with a top Zacks Rank and solid price upside in the short term. These two stocks are: AppLovin Corp. APP and Duolingo Inc. DUOL. Each of our picks currently carries either a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today's Zacks #1 Rank stocks here. The global shift toward digitization creates opportunities in various markets, including 5G, blockchain and AI. Companies are adopting generative AI, machine language (ML), blockchain and data science faster to gain a competitive advantage. The business software industry is gaining from robust demand for multi-cloud-enabled software solutions, given the ongoing transition from legacy platforms to modern cloud-based infrastructure. Industry players are incorporating AI and ML into their applications to achieve more dynamic and result-oriented outcomes. Elevated demand for enterprise software, which is ramping up productivity and improving the decision-making process, is a key catalyst. Zacks Rank #1 AppLovin is engaged in building a software-based platform for mobile app developers to enhance the marketing and monetization of their apps in the United States and internationally. APP provides a technology platform that enables developers to market, monetize, analyze and publish their apps. AppLovin's last reported financial results demonstrate its strong fundamentals and growth potential. The introduction of APP's AI-powered AXON 2.0 technology and strategic expansion in gaming studios have significantly boosted revenue growth. APP's AI-enabled Audience+ marketing platform is also increasing its reach into the direct-to-consumer and e-commerce space. The average short-term price target of brokerage firms represents an increase of 37% from the last closing price of $341.64. The brokerage target price is currently in the range of $200-$650. This indicates a maximum upside of 90.3% and a downside of 41.5%. AppLovin has an expected revenue and earnings growth rate of 16% and 84.8%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.1% in the last seven days. Image Source: Zacks Investment Research Zacks Rank #2 Duolingo operates as a mobile learning platform in the United States, China, the United Kingdom, and internationally. DUOL offers courses in 40 different languages through the Duolingo app. Moreover, DUOL provides a digital language proficiency assessment exam. Duolingo utilizes several AI applications to personalize and automate learning process, error analyzing and content creation. Its Birdbrain AI system analyze real-time user performance. DUOL uses OpenAI's large language models for content creation. The average short-term price target of brokerage firms represents an increase of 24% from the last closing price of $391.86. The brokerage target price is currently in the range of $375-$600. This indicates a maximum upside of 53.1% and a downside of 4.3%. DUOL has an expected revenue and earnings growth rate of 33.5% and 54.3%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 2.1% over the last 60 days. Image Source: Zacks Investment Research Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AppLovin Corporation (APP) : Free Stock Analysis Report Duolingo, Inc. (DUOL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store